Page 5 - Research Models News Today

Rhenman & Partners Asset Management AB trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 13.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,000 shares of the medical research company’s stock after […]

Qtron Investments LLC boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 38.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,149 shares of the medical research company’s stock after acquiring an additional 596 shares during the period. […]

Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. A number of other equities analysts have also recently commented on CRL. Citigroup lifted their price objective on shares of Charles River Laboratories […]

StockNews.com upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a research note released on Friday morning. Other equities analysts have also recently issued research reports about the stock. Citigroup raised their target price on shares of Charles River Laboratories International from $215.00 to […]

AMG National Trust Bank lessened its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,654 shares of the medical research company’s stock after selling 55 shares […]

Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) shares dropped 4.1% on Thursday . The company traded as low as $220.44 and last traded at $223.00. Approximately 273,632 shares traded hands during trading, a decline of 50% from the average daily volume of 546,376 shares. The stock had previously closed at $232.56. Analysts […]

Inotiv (NASDAQ:NOTV – Get Free Report)‘s stock had its “hold” rating reissued by research analysts at Lake Street Capital in a report issued on Thursday, Benzinga reports. They currently have a $2.00 target price on the stock, down from their prior target price of $10.00. Lake Street Capital’s target price would suggest a potential downside […]

Inotiv (NASDAQ:NOTV – Get Free Report)‘s stock had its “hold” rating reaffirmed by research analysts at Lake Street Capital in a report released on Thursday, Benzinga reports. They currently have a $2.00 target price on the stock, down from their previous target price of $10.00. Lake Street Capital’s price objective suggests a potential downside of […]

Atria Wealth Solutions Inc. decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,162 shares of the medical research company’s stock after selling 105 […]

Van ECK Associates Corp lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 57,679 shares of the medical research company’s stock after selling 5,418 shares during the period. Van ECK Associates […]